Secondhand Cannabis Smoke: Is It Actually Harmful?

The Question People Are Actually Asking

You’re at a concert. A group nearby is passing a joint around. Someone nudges you and jokes, “You’re going to get a contact high whether you want one or not.” Is that true? And if it is, does it mean something is also happening to your blood vessels that you can’t feel?

These two questions — the contact high myth and the less-discussed cardiovascular risk — sit at the center of what scientists know (and are still figuring out) about secondhand cannabis smoke. And as cannabis becomes legal across more states and more people are exposed in shared indoor spaces, cars, and homes, this conversation matters more than ever.

Here’s the short version: The classic contact high from casual exposure is mostly myth under normal conditions. But “mostly myth” is doing a lot of work in that sentence. The health risks of secondhand cannabis smoke, particularly for your heart and blood vessels, are real and have been documented by credentialed research teams at institutions like UC San Francisco and Johns Hopkins.

Let’s separate the myths from the meaningful science.

The Contact High Question: What the Studies Actually Found

“Contact high” has been folklore in cannabis culture for decades. The idea: breathe the same air as someone smoking, feel a buzz. Movies have played this for laughs. But what does the controlled research say?

The most rigorous set of studies on this question came out of Johns Hopkins University and the National Institute on Drug Abuse (NIDA), published in a three-part series in the Journal of Analytical Toxicology (2015). Here’s what the researchers did: they placed six non-cannabis-using participants in a sealed chamber with six cannabis smokers who were each smoking cigarettes with 11.3% THC for a full hour, with no ventilation. These were intentionally extreme conditions, designed to be the outer limit of what someone might realistically experience.

Under those extreme, unventilated conditions:

• Non-smokers showed detectable THC in blood and oral fluid for up to 3 hours after exposure.
• Some participants reported mild subjective effects — slight sedation and feeling somewhat altered.
• Urine tests came back positive at lower cutoff thresholds (20 ng/mL) but not at the standard 50 ng/mL threshold used by most workplace drug screens.

When the researchers repeated the experiment with ventilation, the results were dramatically different. Blood cannabinoid levels were much lower, there were no meaningful subjective drug effects, no performance impairments, and urine tests came back clean [Herrmann et al., 2015].

The takeaway: A contact high is physiologically possible, but it requires conditions that are genuinely extreme — an enclosed, unventilated space with multiple heavy smokers for an extended period. A backyard session, a concert, or a room with an open window? Not enough to create meaningful intoxication in a bystander. The story your buddy tells about “getting baked from the contact high at a festival” is almost certainly embellishment.

But here’s where it gets more complicated — and more important.

The Cardiovascular Findings That Should Get More Attention

In 2016, a team at UCSF published a paper in the Journal of the American Heart Association that changed how serious researchers think about secondhand cannabis smoke [Wang et al., 2016]. It’s important to note upfront: this study was conducted in rats, not humans. That caveat matters — but it doesn’t eliminate the concern. What the researchers found was startling in its simplicity: just one minute of exposure to secondhand cannabis smoke impaired vascular endothelial function, and the impairment lasted for at least 90 minutes.

To understand why that matters, you need to understand what the endothelium does. The endothelium is the thin layer of cells lining your blood vessels. When it’s healthy, your arteries dilate properly in response to increased blood flow (a process called flow-mediated dilation, or FMD). Research suggests this flexibility plays a central role in reducing the risk of atherosclerosis, heart attacks, and stroke. When endothelial function is impaired, even transiently, scientists believe the result is a measurable increase in cardiovascular risk.

Here’s the part that makes this finding stand out: one minute of tobacco secondhand smoke also impaired FMD in the same model — but rats recovered within 30 minutes. With cannabis smoke, the impairment was still measurable at 90 minutes. Researchers interpreted this as suggesting cannabis secondhand smoke may produce longer-lasting cardiovascular disruption than tobacco at comparable exposure levels — though translating this to human clinical outcomes requires further longitudinal study in people.

The researchers went further. They showed that this impairment wasn’t caused by cannabinoids (THC, CBD), nicotine, or even the rolling paper smoke. It’s the smoke itself — the particulate matter and combustion byproducts — doing the damage. This has significant implications: it means low-THC cannabis, hemp, and even non-psychoactive cannabis products, when smoked, could carry similar cardiovascular risks through secondhand exposure.

A 2023 follow-up study from the same lab, published in the Journal of the American Heart Association, extended this finding to cannabis leaf vaporizers. Even aerosol from dry herb vaporizers (which heat flower without combustion) impaired endothelial function in rats by approximately 50%, regardless of cannabinoid content or vaporizing temperature [Springer et al., 2023]. This challenges the popular assumption that vaping is meaningfully safer for bystanders from a cardiovascular standpoint.

What About Respiratory Effects?

The cardiovascular research is the newest and most surprising. But the respiratory picture has been building for years.

A 2022 study published in JAMA Network Open measured fine particulate matter (PM2.5) levels during social cannabis bong smoking in a home environment — and the numbers are difficult to dismiss [Nguyen & Hammond, 2022]. During the first 15 minutes of a typical session, mean PM2.5 concentrations reached 570 micrograms per cubic meter — more than twice the US EPA’s “hazardous air quality” threshold of 250 µg/m³. Cannabis bong smoking generated 4 times greater PM2.5 concentrations than cigarette smoking in the same indoor space.

For context: the EPA’s daily air quality standard is 35 µg/m³. A single home bong session with no other exposures would generate estimated daily concentrations of 200 µg/m³ — nearly six times the safe limit.

These are not abstract numbers. Chronic exposure to PM2.5 at high concentrations is causally linked to respiratory inflammation, reduced lung function, and increased risk of cardiovascular events. This isn’t just a cannabis-specific concern — it’s a combustion and particulate concern that happens to apply directly to cannabis use.

A large 2024 study from Oklahoma (N=5,410) confirmed the real-world picture: 42% of adults surveyed reported secondhand cannabis smoke exposure in the past 30 days, and exposure was independently associated with increased respiratory symptoms — even among people who didn’t use cannabis themselves [Cohn et al., 2024, Preventive Medicine Reports]. The effect was strongest for those exposed in home environments and vehicles.

One critical note here: cannabis smoke has not been consistently linked to lung cancer in the same way tobacco smoke has — a finding that holds for both active smokers (the landmark Tashkin research) and, by extension, secondhand exposure. The respiratory picture for cannabis is genuinely different from tobacco in some important ways. But “probably not carcinogenic” is a very different statement from “safe to breathe.”

If you want to understand what’s happening to your lungs more broadly when cannabis smoke is involved, our deep-dive on cannabis and lung health covers the full picture for active smokers.

Vape vs. Flower: Does It Matter for Bystanders?

This is a question a lot of people assume they know the answer to. If vaping doesn’t produce combustion smoke, surely it’s safer for people nearby, right?

The cardiovascular data says: not necessarily. The 2023 Springer lab study found comparable endothelial function impairment from cannabis vaporizer aerosol versus cannabis smoke. The mechanism appears to be the aerosol particles themselves — not the combustion byproducts specifically.

That said, there’s nuance here worth acknowledging:

• Dry herb vaporizers produce lower PM2.5 than combustion and fewer known toxicants, but still measurably impair endothelial function in animal models.
• Vape pens and oil cartridges produce aerosol with different chemical compositions. Some studies have found higher concentrations of certain aldehydes (formaldehyde, acetaldehyde) from vaporized CBD products compared to other methods.
• Edibles produce zero secondhand exposure through inhalation — there’s no smoke or aerosol involved.

If you’re choosing a method with bystander exposure in mind, edibles eliminate the problem entirely. Among inhalation methods, a well-maintained vaporizer likely reduces — but does not eliminate — the cardiovascular risk to people nearby. For more on how cannabis moves through your body after ingestion, our pharmacokinetics guide covers the full absorption and elimination picture.

The Groups Most at Risk

Not everyone faces the same exposure risk. Research points to several groups where the concern is elevated:

Children

This is where the data is most unambiguous about the need for caution. A 2017 study from the Icahn School of Medicine at Mount Sinai tested urine samples from 43 children (ages 1 month to 2 years) hospitalized in Colorado for bronchiolitis. 16% had detectable THC metabolites (COOH-THC) in their urine — indicating meaningful cannabinoid exposure [Wilson et al., 2017, Pediatric Research]. Among children also exposed to tobacco smoke, the rate of detectable COOH-THC was 56%.

Children have smaller body mass, faster respiratory rates, and developing neurological systems that may be more vulnerable to cannabinoid disruption. The CDC has explicitly noted that “THC can be passed to infants and children through secondhand smoke, and people exposed to secondhand cannabis smoke can experience psychoactive effects.” The developing teenage brain, in particular, shows sensitivity to cannabis exposure — a topic covered in the broader body of adolescent cannabis research.

Pets

Animals in cannabis-using households face their own risks. Dogs and cats can be exposed through secondhand smoke in enclosed spaces, and their smaller body weight means even trace exposure can produce more pronounced effects. Cannabis poisoning in pets is increasingly documented as legalization expands, though this typically involves ingestion rather than secondhand smoke exposure. Our cannabis and pets research guide covers this territory in detail.

People with Pre-existing Cardiovascular Conditions

Given the endothelial function impairment findings, people with existing heart disease, hypertension, or atherosclerosis have particular reason to avoid secondhand cannabis smoke. The cardiovascular research on cannabis and heart health covers the active-use side of this equation, but the secondhand data points in the same direction.

Drug Testing and Legal Concerns

One of the most practically urgent concerns for many people: can secondhand cannabis smoke cause a failed drug test? This is the question that keeps people up at night, especially in states with workplace drug testing programs.

The Johns Hopkins sealed-chamber studies give us the most rigorous answer: under normal, real-world conditions with any ventilation, secondhand exposure does not produce the cannabinoid levels needed to fail a standard 50 ng/mL urine test cutoff. The extreme sealed-room scenario that produced positive tests at the 20 ng/mL threshold is not representative of what happens at a cookout, in a car with open windows, or in most indoor social settings.

That said: if you’re subject to zero-tolerance drug testing, a policy of avoidance is the only genuinely safe approach. The data showing THC detectable in blood and oral fluid for up to 3 hours after extreme exposure is real, even if the conditions required are unusual. For a full breakdown of how THC behaves in your system and testing detection windows, see our cannabis and drug testing guide.

Secondhand Cannabis vs. Secondhand Tobacco: How Do They Compare?

The comparison to tobacco secondhand smoke is worth examining directly, because the two are often either conflated or treated as completely separate phenomena.

Similarities:

• Both contain combustion byproducts including polycyclic aromatic hydrocarbons (PAHs), known carcinogens
• Cannabis smoke contains some toxicants at higher concentrations than tobacco — ammonia levels in secondhand cannabis smoke have been measured at up to 20 times those in tobacco secondhand smoke
• Both impair endothelial function through similar mechanisms
• Both increase indoor PM2.5 to harmful levels

Key differences:

• Cannabis secondhand smoke has not been linked to lung cancer in the same way tobacco has — the carcinogenic risk profile appears different even if combustion byproducts overlap
• Cannabis secondhand smoke contains THC, a psychoactive compound that tobacco smoke does not — meaning bystanders can experience pharmacological effects that go beyond smoke-related irritation
• The endothelial function impairment from cannabis secondhand smoke appears to last longer than from tobacco at equivalent exposures, which may have different chronic risk implications
• The cultural and legal frameworks are different — indoor smoking bans cover tobacco universally but cannabis coverage varies widely by jurisdiction

The 2024 U.S. Surgeon General’s Report directly addressed this: “secondhand cannabis smoke contains many of the same toxic and cancer-causing chemicals found in tobacco smoke and some in higher amounts.” This language represents the federal health establishment’s clearest statement yet on the subject.

Practical Harm Reduction for Consumers and Bystanders

Understanding the science leads naturally to some practical guidance. If you use cannabis and care about the people around you, here’s what the research supports:

Ventilate aggressively. The Johns Hopkins studies showed that ventilation was the single biggest factor reducing secondhand exposure. An open window, an exhaust fan, or moving outdoors makes an enormous difference. The sealed, unventilated room scenario that produced meaningful exposure effects is largely avoidable.

Smoke outdoors when possible. Open-air exposure dissipates rapidly. Outdoor concert exposure, even at high-density events, produces a fraction of the indoor exposure that drove the concerning study findings.

Never smoke around children. The research on THC metabolites in children is too clear to dismiss. Children’s developing systems face disproportionate risk.

Consider non-combustion alternatives. If secondhand exposure to housemates or family members is a concern, edibles eliminate the airborne risk entirely. Vaporizers reduce but don’t eliminate it.

If you’re a non-user concerned about exposure: Opening windows and doors, leaving enclosed spaces during smoking sessions, and advocating for outdoor-only consumption in shared living situations are all evidence-backed approaches.

Professor High’s Honest Assessment

Here’s where we land after going through the research: the contact high myth is mostly busted — normal, ventilated real-world conditions don’t produce meaningful intoxication in bystanders. That’s genuinely reassuring.

But “not high” is not the same as “no effect.” The cardiovascular data from UC San Francisco is difficult to dismiss. The particulate matter findings from the JAMA Network Open bong study are striking. And the THC metabolite data in children is a clear signal that in-home smoking around vulnerable populations carries real consequences.

The honest scientific position is that we know enough to be more careful than the cannabis culture has historically been — but we don’t have the decades of epidemiological data on secondhand cannabis smoke that we have for tobacco. More research on chronic secondhand exposure is urgently needed as legalization expands.

In the meantime: know the conditions under which exposure actually becomes a risk, ventilate aggressively, protect children and vulnerable people, and make informed choices about your consumption method. Cannabis can be part of a responsible lifestyle — and understanding the full picture of who your consumption affects is part of that responsibility.

Key Takeaways

• The contact high is largely myth under normal conditions. Meaningful intoxication from secondhand exposure requires an extreme scenario: enclosed, unventilated space, multiple heavy smokers, one hour or more. Add any ventilation and the effect essentially disappears.
• The cardiovascular risk is real and underappreciated. Just one minute of secondhand cannabis smoke may impair vascular endothelial function for up to 90 minutes — longer than comparable tobacco exposure — based on animal research.
• PM2.5 from indoor cannabis smoking may exceed EPA hazardous thresholds rapidly. Bong smoking in a home can push particulate levels to more than twice the EPA’s hazardous air quality threshold within 15 minutes.
• Children are the most vulnerable group. THC metabolites have been detected in the urine of infants and toddlers in cannabis-using households. Developmental neurological systems may be particularly sensitive.
• Vaporizers reduce but may not eliminate the cardiovascular risk to bystanders. Animal studies suggest that dry herb vaporizer aerosol impairs endothelial function comparably to combusted smoke.
• Ventilation is the most effective real-world harm reduction tool. Open windows, outdoor consumption, and exhaust fans substantially reduce bystander exposure to both PM2.5 and cannabinoids.
• Drug test failure from casual secondhand exposure is unlikely at standard 50 ng/mL cutoffs under normal, ventilated conditions — but not impossible under extreme unventilated exposure.

Sources

1. Cone EJ, Bigelow GE, Herrmann ES, et al. Nonsmoker Exposure to Secondhand Cannabis Smoke. III. Oral Fluid and Blood Drug Concentrations and Corresponding Subjective Effects. J Anal Toxicol. 2015;39(7):497–509. PubMed

2. Herrmann ES, Cone EJ, Mitchell JM, et al. Non-smoker exposure to secondhand cannabis smoke II: Effect of room ventilation on the physiological, subjective, and behavioral/cognitive effects. Drug Alcohol Depend. 2015;151:194–202.

3. Wang X, Derakhshandeh R, Liu J, et al. One Minute of Marijuana Secondhand Smoke Exposure Substantially Impairs Vascular Endothelial Function. J Am Heart Assoc. 2016;5(8):e003858. PMC

4. Springer ML, et al. Impairment of Endothelial Function by Aerosol From Marijuana Leaf Vaporizers. J Am Heart Assoc. 2023. doi:10.1161/JAHA.123.032969

5. Nguyen PK, Hammond SK. Fine Particulate Matter Exposure From Secondhand Cannabis Bong Smoking. JAMA Netw Open. 2022;5(3):e224744. PMC

6. Cohn AM, et al. Secondhand cannabis smoke exposure and respiratory symptoms among adults living in a state with legalized medical cannabis. Prev Med Rep. 2024;45:102835. PMC

7. Wilson KM, Torok MR, Wei B, et al. Detecting biomarkers of secondhand marijuana smoke in young children. Pediatr Res. 2017;81(4):589–592. PMC

8. Moir D, Rickert WS, Levasseur G, et al. A comparison of mainstream and sidestream marijuana and tobacco cigarette smoke. Chem Res Toxicol. 2008;21(2):494–502.

9. Centers for Disease Control and Prevention. Cannabis and Secondhand Smoke. Updated February 15, 2024. CDC